Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Genes & Diseases(2022)10.1016/j.gendis.2022.09.013Source: DataRank Database

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer is a research paper published in Genes & Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.16)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Qinglei Hang ORCID,Hongqi Teng ORCID,Fan Yao ORCID,Mei‐Kuang Chen ORCID,Mien‐Chie Hung ORCID

Live enrichment

PubMed:37492703 PMC:PMC10363626 OpenAlex:https://openalex.org/W4306255290

Cancer Prevention and Research Institute of Texas

Grant: RP190029

National Institutes of Health

Grant: P30CA016672

National Institutes of Health

Grant: R01CA166051

FWCI

0.16

Citation Percentile

0.4%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2352304222002665/pdf

GOLDhttps://www.sciencedirect.com/science/article/pii/S2352304222002665/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2352304222002665/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352304222002665?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352304222002665?httpAccept=text/plain

Fields of Study

Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysDNA Repair MechanismsMedicine

Keywords

RadioresistanceTriple-negative breast cancerDeubiquitinating enzymePARP inhibitorBreast cancerCancerOlaparibCancer researchPoly ADP ribose polymeraseMedicineOncologyBiologyInternal medicineGeneticsGeneRadiation therapyUbiquitinPolymerase

Sustainable Development Goals

SDG 0: Good health and well-being